Sphere Medical Holding PLC’s (SPHR) Buy Rating Reaffirmed at Panmure Gordon
Sphere Medical Holding PLC (LON:SPHR)‘s stock had its “buy” rating restated by analysts at Panmure Gordon in a research note issued on Thursday. They presently have a GBX 17 ($0.22) price target on the stock. Panmure Gordon’s price objective would suggest a potential upside of 36.00% from the stock’s previous close.
Sphere Medical Holding PLC (LON:SPHR) opened at 12.7999 on Thursday. The stock has a 50 day moving average price of GBX 11.37 and a 200 day moving average price of GBX 11.00. Sphere Medical Holding PLC has a 52 week low of GBX 6.00 and a 52 week high of GBX 15.00. The stock’s market capitalization is GBX 18.14 million.
About Sphere Medical Holding PLC
Sphere Medical Holding PLC is a United Kingdom-based Company specializing in the development of medical monitoring and diagnostic equipment. The Company’s products include Proxima and Pelorus. Proxima is an arterial blood gas analyser which supports rapid and frequent measurement. It is operated using the dedicated bedside monitor with touch screen interface.
Receive News & Ratings for Sphere Medical Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere Medical Holding PLC and related companies with MarketBeat.com's FREE daily email newsletter.